API depletes anti-apoptotic Bcl2 and increases pro-apoptotic caspase 3 whereas miR-155 increases anti-apoptotic Bcl2 and decreases pro-apoptotic caspase 3 in cancer cells [51,82]. Here, CASP3 is linked to cancer.